首页 | 本学科首页   官方微博 | 高级检索  
     

乳腺癌患者血清miR-765,miR-200b水平检测及与临床病理学相关研究
引用本文:洪 宏,袁建芬,喻海忠. 乳腺癌患者血清miR-765,miR-200b水平检测及与临床病理学相关研究[J]. 现代检验医学杂志, 2018, 0(6): 55-58. DOI: 10.3969/j.issn.1671-7414.2018.06.014
作者姓名:洪 宏  袁建芬  喻海忠
作者单位:南通市中医院检验科,江苏南通 226001
摘    要:目的 探讨乳腺癌患者血清miR-765与miR-200b的表达及其临床应用价值。方法 选取乳腺癌患者58例,乳腺良性疾病患者28例及体检健康者30例,应用实时荧光定量PCR技术检测血清miR-765和miR-200b的表达水平,评价指标的诊断价值,并分析与乳腺癌临床病理特征的相关性。结果 乳腺癌患者血清miR-765和miR-200b相对表达量均显著性低于乳腺良性疾病患者(t=3.955,2.657,P<0.05)和健康对照者(t=4.465,3.518,P<0.05)。ROC曲线分析结果显示,miR-765在乳腺癌诊断中的AUC为0.843(95%CI:0.767~0.919),miR-200b在乳腺癌诊断中的AUC为0.897(95%CI:0837~0.957)。miR-765联合miR-200b在乳腺癌诊断中的AUC为0.952(95%CI:0.941~0.990),两者联合优于单一检测miR-765或miR-200b。在乳腺癌患者中血清miR-765相对表达量与临床分期相关(t=3.222,P<0.05); miR-200b相对表达量与临床分期、淋巴结转移相关(t=1.855,3.987,P均<0.05)。结论 乳腺癌患者血清miR-765与miR-200b表达水平显著降低,并与乳腺癌临床病理特征明显相关,血清miR-765与miR-200b联合检测具有较高的临床应用价值。

关 键 词:微小RNA-765  微小RNA-200b  实时荧光定量聚合酶链反应  乳腺癌

Detection of Serum miR-765 and miR-200b Levels in Breast Cancer Patients and Its Correlation with Clinicopathology
HONG Hong,YUAN Jian-fen,YU Hai-zhong. Detection of Serum miR-765 and miR-200b Levels in Breast Cancer Patients and Its Correlation with Clinicopathology[J]. Journal of Modern Laboratory Medicine, 2018, 0(6): 55-58. DOI: 10.3969/j.issn.1671-7414.2018.06.014
Authors:HONG Hong  YUAN Jian-fen  YU Hai-zhong
Affiliation:Department of Clinical Laboratory,Nantong Hospital of Traditional Chinese Medicine,Jiangsu Nantong 226001,China
Abstract:Objective To explore the relative expression ofserum miR-765 and miR-200b in breast carcinoma patients and its clinical value.Methods 58 cases of patients with breast cancer,28 cases of patients with benign breast disease and 30 cases of healthy individuals were selected.The expression levels of serum miR-765 and miR-200b were determined by fluorescence quantitative PCR.The diagnostic value were evaluated,and the correlation between miRNAs expression and clinicopathological features of breast cancer were analyzed.Result The relative expressionlevels of miR-765 and miR-200b in breast carcinoma patients were significantlylower than those in benign breast disease(t=3.955,2.657,P<0.05)andhealthy controls(t=4.465,3.518,P<0.05).ROC curve analysis showed that,in the diagnosis of breast cancer,AUC value of miR-765 was 0.843(95%CI:0.767~0.919),AUC value of miR-200b was 0.897(95%CI:0837~0.957),AUC value of miR-765 combined with miR-200b in the diagnosis of breast was 0.952(95%CI:0.941~0.990),which was better than a single detector miR-765 or miR-200b.In the cancer patients,low miR-765 relative expression was significantlycorrelated to advanced clinical stage(t=3.222,P<0.05),and low miR-200b relative expression was significantly correlated to advanced clinical stage(t=1.855,P<0.05)and lymph node metastasis(t=3.987,P<0.05).Conclusion Levels of miR-765 and miR-200b in serum of breast carcinoma patients were reduced significantly,and had a significant correlation with the clinicopathological features of breast cancer.There is a high clinical value of combed detection of miR-765 with miR-200b to breast cancer.
Keywords:
本文献已被 CNKI 等数据库收录!
点击此处可从《现代检验医学杂志》浏览原始摘要信息
点击此处可从《现代检验医学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号